Livagen
Khavinson liver bioregulator
Livagen is a Khavinson tetrapeptide bioregulator (Lys-Glu-Asp-Ala / KEDA) originally isolated from liver tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for hepatocyte function, chromatin decondensation in lymphocytes, and liver-related ageing parameters, alongside other organ-targeted Khavinson peptides such as Pancragen and Cortagen. Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
Also known as: KEDA, Liver bioregulator
Cost-per-dose recalculates as you adjust the calculator above.
Livagen · 20mg
| Vendor | Grade | Risk | Price | $/mg | Trend | $/dose at 0.25 mg | Stock | |
|---|---|---|---|---|---|---|---|---|
| Pure Lab Peptides US | B- | Operational | $54.99 ◎ Best $/mg | $2.75 | $0.69 | In stock | Buy with code → | |
| Core Peptides US | A | Operational | $73.00 ▲ 32.8% | $3.65 | $0.91 | In stock | Visit → | |
| BioLongevity Labs US | B | Operational | $79.97 ▲ 45.4% | $4.00 | $1.00 | In stock | Visit → |
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.